Purchase
Description
Denosumab biosimilar is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Denosumab biosimilar is supplied at a concentration of 70 mg/mL as a sterile, preservative-free, clear, colorless to pale yellow solution, which contains acetate (18mM), polysorbate 20 (0.01%), sorbitol (4.6%), Water for Injection and sodium hydroxide to a pH of 5.2.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Denosumab biosimilar
|
|
CAS
NO.
|
615258-40-7
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
RANK ligand
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
147 kDa
|
|
Formula
|
C6404H9912N1724O2004S50
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508153991729172.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Denosumab
|
